Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New PR on share buyback
I agree with you to some extent. They could have announced how many shares they puchased. Sometimes I feel that they do take advantage of the stated silence due to litigation and their master agreement with TPL.
Share
New Message
Please login to post a reply